Reporting Segment Product Linearrow_drop_up Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
BioTech Drug Design
Pre-Revenue Gene Editing Pharmaceuticals
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
78.12M 100.00%
keyboard_arrow_right keyboard_arrow_down
BioTech Drug Design
Pre-Revenue Gene Editing Pharmaceuticals
78.12M 100.00%
keyboard_arrow_right
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.